187 related articles for article (PubMed ID: 15705277)
21. A multicentre double-blind randomised controlled trial evaluating the efficacy of daily use of antibacterial mouthwash against oropharyngeal gonorrhoea among men who have sex with men: the OMEGA (Oral Mouthwash use to Eradicate GonorrhoeA) study protocol.
Chow EPF; Walker S; Hocking JS; Bradshaw CS; Chen MY; Tabrizi SN; Howden BP; Law MG; Maddaford K; Read TRH; Lewis DA; Whiley DM; Zhang L; Grulich AE; Kaldor JM; Cornelisse VJ; Phillips S; Donovan B; McNulty AM; Templeton DJ; Roth N; Moore R; Fairley CK
BMC Infect Dis; 2017 Jun; 17(1):456. PubMed ID: 28659133
[TBL] [Abstract][Full Text] [Related]
22. Cefixime-resistant Neisseria gonorrhoeae in the UK: a time to reflect on practice and recommendations.
Forsyth S; Penney P; Rooney G
Int J STD AIDS; 2011 May; 22(5):296-7. PubMed ID: 21571983
[TBL] [Abstract][Full Text] [Related]
23. Amoxycillin in single oral dose for uncomplicated gonorrhoea.
Platts WM
N Z Med J; 1976 Jul; 84(568):56-8. PubMed ID: 824582
[TBL] [Abstract][Full Text] [Related]
24. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods.
Tapsall J; Read P; Carmody C; Bourne C; Ray S; Limnios A; Sloots T; Whiley D
J Med Microbiol; 2009 May; 58(Pt 5):683-687. PubMed ID: 19369534
[TBL] [Abstract][Full Text] [Related]
25. An open study of procaine penicillin G, clavulanate-potentiated amoxycillin and probenecid in the treatment of acute gonorrhoea.
Ekwere PD
J Int Med Res; 1994; 22(4):236-43. PubMed ID: 7958383
[TBL] [Abstract][Full Text] [Related]
26. Further evidence to support the individualised treatment of gonorrhoea with ciprofloxacin.
Trembizki E; Guy R; Donovan B; Kaldor JM; Lahra MM; Whiley DM;
Lancet Infect Dis; 2016 Sep; 16(9):1005-1006. PubMed ID: 27684341
[No Abstract] [Full Text] [Related]
27. Gonorrhoea treatment failure and ciprofloxacin resistance.
Ng PP; Chan RK; Ling AE
Int J STD AIDS; 1998 Jun; 9(6):323-5. PubMed ID: 9671244
[TBL] [Abstract][Full Text] [Related]
28. UK national guideline for the management of gonorrhoea in adults, 2011.
Bignell C; Fitzgerald M; ;
Int J STD AIDS; 2011 Oct; 22(10):541-7. PubMed ID: 21998172
[TBL] [Abstract][Full Text] [Related]
29. Testing for pharyngeal gonorrhoea in heterosexual men: should we revisit national guidelines?
Dresser M; Hussey J
Int J STD AIDS; 2020 May; 31(6):593-595. PubMed ID: 32295478
[No Abstract] [Full Text] [Related]
30. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M
J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907
[TBL] [Abstract][Full Text] [Related]
31. Pharyngeal gonorrhoea - is dual therapy the way forward?
Sathia L; Ellis B; Phillip S; Winston A; Smith A
Int J STD AIDS; 2007 Sep; 18(9):647-8. PubMed ID: 17785013
[No Abstract] [Full Text] [Related]
32. Isolated pharyngeal Neisseria gonorrhoeae in heterosexual male contacts.
Thomson-Glover R; Brown R; Edirisinghe DN
Int J STD AIDS; 2013 Dec; 24(12):983-5. PubMed ID: 23970625
[TBL] [Abstract][Full Text] [Related]
33. Australian Gonococcal Surveillance Programme, 1 July to 30 September 2015.
Lahra MM; Enriquez RP;
Commun Dis Intell Q Rep; 2016 Mar; 40(1):E179-81. PubMed ID: 27080026
[No Abstract] [Full Text] [Related]
34. Non-culture Neisseria gonorrhoeae molecular penicillinase production surveillance demonstrates the long-term success of empirical dual therapy and informs gonorrhoea management guidelines in a highly endemic setting.
Speers DJ; Fisk RE; Goire N; Mak DB
J Antimicrob Chemother; 2014 May; 69(5):1243-7. PubMed ID: 24379305
[TBL] [Abstract][Full Text] [Related]
35. Azithromycin in the treatment of infection with Neisseria gonorrhoeae.
Bignell C; Garley J
Sex Transm Infect; 2010 Nov; 86(6):422-6. PubMed ID: 20940153
[TBL] [Abstract][Full Text] [Related]
36. Ciprofloxacin resistant Neisseria gonorrhoeae in South Africa.
Moodley P; Moodley D; Willem Sturm A
Int J Antimicrob Agents; 2004 Aug; 24(2):192-3. PubMed ID: 15288322
[No Abstract] [Full Text] [Related]
37. Single dose therapy of anogenital and pharyngeal gonorrhoea with ciprofloxacin.
Wardropper A; Pattman RS
Int J STD AIDS; 1992; 3(5):372. PubMed ID: 1391071
[No Abstract] [Full Text] [Related]
38. Test of Cure for Anogenital Gonorrhoea Using Modern RNA-Based and DNA-Based Nucleic Acid Amplification Tests: A Prospective Cohort Study.
Wind CM; Schim van der Loeff MF; Unemo M; Schuurman R; van Dam AP; de Vries HJC
Clin Infect Dis; 2016 Jun; 62(11):1348-1355. PubMed ID: 26962074
[TBL] [Abstract][Full Text] [Related]
39. Low prevalence of ciprofloxacin-resistant Neisseria gonorrhoeae in Nuuk, Greenland.
Pedersen ML; Clausen-Dichow P; Poulsen P; Nyborg H; Jensen JS
Sex Transm Dis; 2013 Aug; 40(8):639-40. PubMed ID: 23859910
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002.
Heffernan H; Brokenshire M; Woodhouse R; MacCarthy A; Blackmore T
N Z Med J; 2004 Apr; 117(1191):U817. PubMed ID: 15107886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
